Enhancing tumor immunity via in vivo cDC1 reprogramming is a research paper published in Trends in Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Cancer Institute
Grant: CA271714
National Heart, Lung, and Blood Institute
Grant: HL63736
National Heart, Lung, and Blood Institute
Grant: HL55337
NHLBI NIH HHS
Grant: R01 HL055337
National Institutes of Health
MeSH Terms